• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Susan Collins’ Maine concession could leave New England without a Republican in Congress for the first time since the 1850s

2

Billionaire Vivek Ramaswamy’s millions and Greg Abbott’s $106 million war chest couldn’t stop Democrats from flipping Texas and Ohio

3

OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a 'trend' of it pivoting resources to defense projects

1

Susan Collins’ Maine concession could leave New England without a Republican in Congress for the first time since the 1850s

2

Billionaire Vivek Ramaswamy’s millions and Greg Abbott’s $106 million war chest couldn’t stop Democrats from flipping Texas and Ohio

3

OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a 'trend' of it pivoting resources to defense projects

Venture capital deals

By
Dan Primack
Dan Primack
Down Arrow Button Icon
By
Dan Primack
Dan Primack
Down Arrow Button Icon
April 2, 2012, 1:54 PM ET
Google source logo
Add Fortune on Google for similar content.

Violin Memory, a Mountain View, Calif.-based flash storage company, has raised $50 million in new VC funding at a valuation north of $800 million. SAP Ventures and Highland Capital Partners were joined by return investors like Toshiba and Juniper Networks. Read more

2tor Inc., a Landover, Mich.-based provider of online degree programs, has raised $26 million in Series D funding. The Hillman Co. led the round, and was joined by SVB Capital, WestRiver Capital and return backers Bessemer Venture Partners, Highland Capital, Redpoint Ventures, Novak Biddle Venture Partners and City Light Capital. The company has now raised $96 million in total VC funding.www.2tor.com

AlloCure Inc., a Burlington, Mass.-based developer of kidney disease treatments, has raised $25 million in Series B funding. Lundbeckfond Ventures led the round, and was joined by return backers SV Life Sciences and Novo AS. www.allocure.com

Good Start Genetics Inc., a Cambridge, Mass.-based developer of carrier screening solutions, has raised $14 million in Series B funding. Return backers include OrbiMed Advisors, Safeguard Scientifics and SV Life Sciences. www.goodstartgenetics.com

Want deal news in your inbox each morning? Get Term Sheet!

About the Author
By Dan Primack
See full bioRight Arrow Button Icon

Latest in


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Recommended For You

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.